反应详情

TFA (0.5 mL) was added to tert-butyl 4-(3-methoxy-1-(4-methoxybenzyl)-5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)piperazine-1-carboxylate (0.098 g, 0.185 mmol) in DCM (2 mL) and stirred at room temperature for 2 hours. The reaction mixture was then concentrated to dryness. The resulting residue was dissolved in TFA (2.85 mL, 37.01 mmol) and heated at 100° C. in a sealed tube for 5 hours. The reaction mixture was again concentrated to dryness. The resulting residue was dissolved in DCM (0.5 mL), followed by the addition of HCl in ether (2 mL, 2N). The resulting solid was collected by filtration to give 3-methoxy-5-phenyl-4-(piperazin-1-yl)-1H-pyrazolo[3,4-b]pyridine (0.068 g, 96%). MS APCI (+) m/z 310.1 detected.

1. concentrationThe reaction mixture was then concentrated to dryness
2. temperatureheated at 100° C. in a sealed tube for 5 hours
3. concentrationThe reaction mixture was again concentrated to dryness
4. dissolutionThe resulting residue was dissolved in DCM (0.5 mL)
5. additionfollowed by the addition of HCl in ether (2 mL, 2N)
6. filtrationThe resulting solid was collected by filtration